AWP Price-Fixing Suit Against McKesson Dismissed; RICO Suits Still Pending
Executive Summary
In a major victory for McKesson, a federal judge dismissed a class action suit alleging the company had engaged in a price-fixing scheme
You may also be interested in...
McKesson Closer To Resolving Multi-Year AWP Legal Saga With $190M Federal Settlement
Wholesale drug distributor McKesson settles charges that it reported inflated average wholesale prices (AWPs) for a large number of branded prescription pharmaceuticals, leading to extensive overpayments by the Medicaid program.
First DataBank, Third-Party Payers Resolve AWP Suit By Cutting WAC Mark-Up
The class action against First Databank over average wholesale pricing may be nearing an end. The parties filed an amended settlement proposal with the court on May 29 under which FDB agreed to roll back AWP prices for hundreds of drugs and put $1 million into a settlement fund
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.